Balance Sheet
Cash Flow Statement
Amortizatization of IntangiblesCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in CashChange in InventoryChange in ReceivablesDeferred TaxesDepreciation & Amortization (CF)Depreciation and DepletionExchange Rate EffectFree Cash FlowGains from Investment SecuritiesGains from Sales and DivestituresNet Cash FlowNet IncomeNon-cash ItemsOther Working Capital ChangesOther financing activitiesShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

CorMedix (CRMD) Capital Expenditures: 2012-2025

Historic Capital Expenditures for CorMedix (CRMD) over the last 9 years, with Sep 2025 value amounting to $505,774.

  • CorMedix's Capital Expenditures rose 5078.93% to $505,774 in Q3 2025 from the same period last year, while for Sep 2025 it was $549,765, marking a year-over-year increase of 355.76%. This contributed to the annual value of $115,730 for FY2024, which is 64.64% down from last year.
  • Latest data reveals that CorMedix reported Capital Expenditures of $505,774 as of Q3 2025, which was up 2,012.23% from $23,945 recorded in Q2 2025.
  • Over the past 5 years, CorMedix's Capital Expenditures peaked at $777,870 during Q3 2021, and registered a low of $4,324 during Q1 2022.
  • For the 3-year period, CorMedix's Capital Expenditures averaged around $83,799, with its median value being $19,356 (2023).
  • Its Capital Expenditures has fluctuated over the past 5 years, first plummeted by 90.18% in 2022, then skyrocketed by 5,078.93% in 2025.
  • CorMedix's Capital Expenditures (Quarterly) stood at $628,761 in 2021, then plummeted by 79.52% to $128,755 in 2022, then skyrocketed by 241.49% to $14,766 in 2023, then skyrocketed by 315.18% to $9,869 in 2024, then spiked by 5,078.93% to $505,774 in 2025.
  • Its last three reported values are $505,774 in Q3 2025, $23,945 for Q2 2025, and $10,177 during Q1 2025.